
News|Articles|November 2, 2004
- Pharmaceutical Technology-11-02-2004
- Volume 28
- Issue 11
Method Validation by Phase of Development: An Acceptable Analytical Practice
This article provides guidance for minimally acceptable method validation practices and a foundation for assessing the risks and benefits associated with method validation programs.
Advertisement
Articles in this issue
over 21 years ago
Still Waiting for Answersover 21 years ago
Comparing and Contrasting Barrier Isolator Decontamination Systemsover 21 years ago
November 2004over 21 years ago
In the Spotlight-November 2004over 21 years ago
Searching for a Viable Business Modelover 21 years ago
FDA Moves To Implement New GMP PoliciesAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5




